Pacific Biosciences of California, Inc. (PACB)
1.285
-0.06
(-4.81%)
USD |
NASDAQ |
Aug 24, 16:00
1.33
+0.04
(+3.50%)
After-Hours: 20:00
Pacific Biosciences of California Gross Profit Margin (Quarterly) : 30.26% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.26% |
| March 31, 2026 | 32.30% |
| December 31, 2025 | 35.24% |
| September 30, 2025 | 39.20% |
| June 30, 2025 | 45.90% |
| March 31, 2025 | -978.2% |
| December 31, 2024 | 13.84% |
| September 30, 2024 | 7.39% |
| June 30, 2024 | 10.23% |
| March 31, 2024 | 11.41% |
| December 31, 2023 | -2.50% |
| September 30, 2023 | 29.80% |
| June 30, 2023 | 32.58% |
| March 31, 2023 | 24.96% |
| December 31, 2022 | 18.63% |
| September 30, 2022 | 41.79% |
| June 30, 2022 | 45.53% |
| March 31, 2022 | 42.53% |
| December 31, 2021 | 46.43% |
| September 30, 2021 | 44.04% |
| June 30, 2021 | 44.93% |
| March 31, 2021 | 44.75% |
| December 31, 2020 | 42.01% |
| September 30, 2020 | 37.02% |
| June 30, 2020 | 38.72% |
| Date | Value |
|---|---|
| March 31, 2020 | 48.01% |
| December 31, 2019 | 46.30% |
| September 30, 2019 | 31.55% |
| June 30, 2019 | 39.04% |
| March 31, 2019 | 31.15% |
| December 31, 2018 | 29.43% |
| September 30, 2018 | 17.58% |
| June 30, 2018 | 41.07% |
| March 31, 2018 | 37.68% |
| December 31, 2017 | 38.08% |
| September 30, 2017 | 34.94% |
| June 30, 2017 | 39.86% |
| March 31, 2017 | 35.87% |
| December 31, 2016 | 44.22% |
| September 30, 2016 | 50.31% |
| June 30, 2016 | 51.30% |
| March 31, 2016 | 49.69% |
| December 31, 2015 | 72.95% |
| September 30, 2015 | 47.07% |
| June 30, 2015 | 58.17% |
| March 31, 2015 | 33.59% |
| December 31, 2014 | 26.25% |
| September 30, 2014 | 63.82% |
| June 30, 2014 | 27.36% |
| March 31, 2014 | 22.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Illumina, Inc. | 66.49% |
| Agilent Technologies, Inc. | 54.01% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Danaher Corp. | 57.64% |
| Thermo Fisher Scientific, Inc. | 40.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -911.4% |
| Return on Assets | -16.64% |
| Return on Invested Capital | -18.33% |
| Profit Margin (Quarterly) | -114.7% |
| Operating Margin (Quarterly) | -114.4% |
| Return on Net Operating Assets | -27.13% |